Surveys Program Shipping · BCP2 KP Blood Cell ID, Limited 139 A 25 B 3 C 20 BCR CRS Bile Crystals...

Surveys Program Shipping

Surveys P

rogram S

hipping

Gain more value from your accreditation program.CAP accreditation is more than “something to check off your list.” It is an opportunity to help keep your laboratory operating at peak performance.

• The CAP offers educational material and support, including highly-trained medical technologists who are available to answer questions.

• The peer inspection model helps participants develop meaningful connections, learn from each other, and share best practices.

Sur

veys

Pro

gram

Shi

ppin

g

Look for notification of kit shipment via CAPTRAKerSM. If you do not receive your kit within 7 –10 calendar days following the ship date, or if you receive an incomplete or damaged shipment, please call the Customer Contact Center at 800-323-4040 or 847-832-7000 option 1. R equests for replacements after the 10th calendar day cannot be accepted.

SM

2021 Surveys Program Shipping

2 College of American Pathologists 2021 Surveys & Anatomic Pathology Education Programs


Prog Code

PFGCode

Description Page Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

A2MG A2MG Alpha-2-Macroglobulin 210 A 8 B 6

AABT AABT Antibody Titer—Automated 227 A 1 B 25

AABT1 AABT Antibody Titer—Automated 227 A 1 B 25



AAT AAT CAP/ACMG Alpha-1 Antitrypsin Genotyping 251 A 26 B 8

ABF1 ABF1 Automated Body Fluid 148 A 16 B 16



ABGIC ABGIC Accuracy-Based Glucose, Insulin, and C-Peptide

115 A 23 B 14

ABL ABL Accuracy-Based Lipids 112 A 15 B 9

ABOSG ABOSG ABO Subgroup Typing 226 A 8 B 26

ABS ABS Accuracy-Based Testosterone, Estradiol 113 A 9 B 13

ABT ABT Antibody Titer, Anti-A and Anti-D 227 A 1 B 25

ABT1 ABT Antibody Titer, Anti-A 227 A 1 B 25

ABT2 ABT Antibody Titer, Anti-D 227 A 1 B 25

ABT3 ABT Antibody Titer, Anti-B 227 A 1 B 25

ABTH ABTH Harmonized Thyroid 114 A 4 B 9

ABU ABU Accuracy-Based Urine 113 A 6 B 14

ABVD ABVD Accuracy-Based Vitamin D 112 A 23 B 5

ACA ACA Antichromatin Antibody 210 A 18 B 2

ACE ACE Angiotensin Converting Enzyme 71 A 29 B 20

ACL ACL Antiphospholipid Antibody 211 A 16 B 1

ADL ADL Aldolase 71 A 17 B 18

AFD AFD Antifungal Drugs Monitoring 107 A 11 B 16

AFL AFL Amniotic Fluid Leakage 148 A 10 B 13

AG AG 1,5-Anhydroglucitol 71 A 29 B 18

AHIV AHIV Anti-HIV 1/2 235 A 29 B 9 C 29

AHIVW AHIVW Anti-HIV 1/2, Waived 235 A 9 B 29

AHT S2 Antihistone Antibody 210 A 6 C 13

AL1 AL1 CAP/AACC Whole Blood Alcohol/Volatiles 102 A 22 B 7 C 27

AL2 AL2 CAP/AACC Serum Alcohol/Volatiles 102 A 8 B 1 C 4

AMH AMH Antimüllerian Hormone 84 A 26 B 8

ANA S Antinuclear Antibody 208 A 22 B 16 C 15

APC GIH Autoimmune Gastritis Markers 210 A 26 B 27

APOE APOE CAP/ACMG Apolipoprotein E Genotyping 251 A 1 B 13

APS ACL Antiphosphatidylserine Antibody 211 A 16 B 1

APT APT Fetal Hemoglobin 150 A 1 B 27

APXBN ACM Apixaban Anticoagulant Monitoring 163 A 12 B 25

Surveys P

rogram S

hipping


SM

2021 Surveys Program Shipping (Continued)


800-323-4040 | 847-832-7000 Option 1 | cap.org 3

Prog Code

PFGCode


AQ AQ Critical Care Blood Gas 92 A 22 B 21 C 18

AQ2 AQ Critical Care Blood Gas with Chemistry 92 A 22 B 21 C 18

AQ2Q AQQ Quality Cross Check—Blood Gas with Chemistry

42 A 22 B 9

AQ3 AQI Critical Care Blood Gas, i-STAT® 92 A 22 B 21 C 18

AQ3Q AQIQ Quality Cross Check—Blood Gas, i-STAT 42 A 22 B 9

AQ4 AQI Critical Care Blood Gas with Chemistry, i-STAT

92 A 22 B 21 C 18

AQ4Q AQIQ Quality Cross Check—Blood Gas with Chemistry, i-STAT

42 A 22 B 9

AQQ AQQ Quality Cross Check—Blood Gas 42 A 22 B 9

ARP ARP Antiribosomal P Antibody 211 A 18 B 23

ASA SEM Antisperm Antibody 156 A 19 B 25

ASC ASC Anti-Saccharomyces cerevisiae Antibody 211 A 10 B 6

ASO S Antistreptolysin O 208 A 22 B 16 C 15

AUP AUP Autopsy Pathology 290 A 22 B 11

AUP1 AUP Autopsy Pathology, Additional Pathologist 290 A 22 B 11

B27 B27 HLA-B27 Typing 240 A 13 B 24

BALL BALL Flow Cytometry—B-ALL Minimal Residual Disease

217 A 13 B 14

BCM BCM Bacterial Blood Culture, Molecular 181 A 26 B 23 C 6

BCP KP Blood Cell ID, Photographs 139 A 25 B 3 C 20

BCP2 KP Blood Cell ID, Limited 139 A 25 B 3 C 20

BCR CRS Bile Crystals 149 A 28 B 29

BCS BCS Blood Culture 180 A 28 B 25

BCS1 BCS1 Blood Culture, S. aureus 181 A 29 B 13

BDP BDP Bacterial Detection in Platelets, 2 Challenge

232 A 19 B 18

BDP5 BDP5 Bacterial Detection in Platelets, 5 Challenge

232 A 19 B 12 C 18

BDPV BDPV Bacterial Detection in Platelets, Rapid, 2 Challenge

232 A 20 B 19

BDPV5 BDPV5 Bacterial Detection in Platelets, Rapid, 5 Challenge

232 A 20 B 13 C 19

BFC CRS Body Fluid Crystals 149 A 28 B 29

BGL BGL CAP/ACMG Biochemical Genetics 249 A 9 B 17

BGL1 BGL CAP/ACMG Carnitine, Qual/Quant 249 A 9 B 17

BGL2 BGL2 Amino Acid Quantitation for Inherited Metabolic Disorders

250 A 25 B 14

BGS Y Bone and Growth 85 A 26 B 20

BL BL CAP/AACC Blood Lead 103 A 15 B 12 C 25

BMD BMD Bone Marrow Cell Differential 139 A 22 B 23

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


BMV1 BMV 1,25 Dihydroxy Vitamin D 86 A 6 B 16

BMV2 BMV Bone-Specific Alkaline Phosphatase 86 A 6 B 16

BMV3 BMV Vitamin A 86 A 6 B 16

BMV4 BMV Vitamin E 86 A 6 B 16

BMV5 BMV C-Telopeptide 86 A 6 B 16

BMV6 BMV N-Telopeptide 86 A 6 B 16

BNP BNP B-Type Natriuretic Peptides, 2 Challenge 59 A 2 B 26

BNP5 BNP5 B-Type Natriuretic Peptides, 5 Challenge 59 A 2 B 8 C 26

BNPQ BNPQ Quality Cross Check—BNP 39 A 26 B 1

BOR BOR B. pertussis/parapertussis, Molecular 183 A 19 B 8

BP BP Blood Parasite 195 A 25 B 17 C 20

BRAF BRAF BRAF 265 A 17 B 29

BRAFV BRAFV BRAF V600E IHC 287 A 17 B 29

BRCA BRCA CAP/ACMG BRCA 1/2 Sequencing 251 A 19 B 8

BSTS BST Bacterial Strain Typing, Staphylococcus 180 A 12 B 16

BU Y Bone and Mineral Metabolism, Urine 85 A 26 B 20

BV BV Bacterial Vaginosis 187 A 29 B 25

C1 C Chemistry—General, Limited 54–56 A 8 B 1 C 27

C3 C Chemistry—General, Comprehensive 54–56 A 8 B 1 C 27

C3X C Chemistry—General, Double Volume 54–56 A 8 B 1 C 27

C4 C Chemistry—Limited 54–56 A 8 B 1 C 27

C7 C Pseudocholinesterase 77 A 8 B 1 C 27

CAMP CAMP Campylobacter 183 A 12 B 16

CBT* CBT Cord Blood Testing 231 A 19 B 3

CCP RDS Cyclic Citrullinated Peptide Antibody (Anti-CCP)

212 A 6 B 16

CD CD Cadmium 103 A 19 B 1 C 1 D 2 E 20 F 22

CD30 CD30 CD30 Immunohistochemistry Tissue Microarray

287 A 22 B 13

CDF2 CDF C. diff, 2 Challenge 183 A 19 C 6

CDF5 CDF C. diff, 5 Challenge 184 A 19 B 9 C 6

CES CES Celiac Serology 212 A 8 B 13

CESX CES Celiac Serology, Additional Volume 212 A 8 B 13

CFDNA CFDNA Cell-free Tumor DNA 265 A 27 B 28

CGB CGL Coagulation—Basic 160 A 25 B 10 C 23

CGDF CGL D-dimer/FDP 160 A 25 B 10 C 23

CGE CGE Coagulation—Extended 161 A 22 B 27

CGEX CGE Coagulation—Extended, Additional Material

161 A 22 B 27

CGL CGL Coagulation—Limited 160 A 25 B 10 C 23

*Ship date subject to change.

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 5

Prog Code

PFGCode


CGLQ CGLQ Quality Cross Check—Coagulation 45 A 6 B 4

CGM CGM Coagulation—Limited, Validated Material 169 A 25 B 10 C 23

CGS1 CGS1 Lupus Anticoagulant and Mixing Studies 162 A 15 B 30

CGS2 CGS2 Thrombophilia 162 A 15 B 30

CGS3 CGS3 von Willebrand Factor Antigen 162 A 15 B 30

CGS4 CGS4 Heparin 162 A 15 B 30

CGS5 CGS5 Heparin-Induced Thrombocytopenia 162 A 12 B 18

CGS7 CGS7 ADAMTS13 162 A 6 B 13

CH50 CH50 Total Hemolytic Complement 214 A 19 B 1

CHPVD CHPV Human Papillomavirus, Digene 295 A 1 B 2 C 13

CHPVJ CHPV Human Papillomavirus, Mixed Media 295 A 1 B 2 C 13

CHPVK CHPV Human Papillomavirus, SurePath 295 A 1 B 2 C 13

CHPVM CHPV Human Papillomavirus, ThinPrep 295 A 1 B 2 C 13

CMMP CM Clinical Microscopy Miscellaneous Photopage

147 A 16 B 7

CMP CM Urinalysis w/Body Fluid & Urine Sediment Photos

146 A 16 B 7

CMP1 CM iChem Urinalysis w/Body Fluid & Urine Sediment Photos

146 A 16 B 7

CMQ CMQ Quality Cross Check—Urinalysis 44 A 10 B 15

CMSP CMSP CAP/ACMG Cardiomyopathy Sequencing Panel

252 A 13 B 12

COV2 COV2 SARS-CoV-2, Molecular 199 A 24 B 22

COV2Q COV2Q Quality Cross Check—SARS-CoV-2 Molecular

48 A 8 B 9

COVAG COVAG SARS-CoV-2 Antigen 198 A 12 B 4

COVAQ COVAQ Quality Cross Check—SARS-CoV-2 Antigen 48 A 17 B 15

COVS COVS SARS-CoV-2 Serology 214 A 7 B 14

COVSQ COVSQ Quality Cross Check—SARS-CoV-2 Serology

48 A 1 B 13

CPIP CPIP Clinical Pathology Improvement Program 14 A 18 B 15 C 15 D 19 E 17 F 21 G 19 H 16 I 20 J 18 K 15 L 20

CPIP1 CPIP Clinical Pathology Improvement Program, Additional Participant

14 A 18 B 15 C 15 D 19 E 17 F 21 G 19 H 16 I 20 J 18 K 15 L 20

CRO CRO Carbapenem-resistant Organisms 183 A 22 B 13

CRP S C-Reactive Protein 208 A 22 B 16 C 15

CRT CAR Cardiac Markers 60 A 16 B 18 C 5

CRTI CAR Cardiac Markers, Isoenzymes & Troponin I 60 A 16 B 18 C 5

CRTQ CRTQ Quality Cross Check—Cardiac Markers 40 A 13 B 14

CRYP CRYP Cryptococcal Antigen Detection 192 A 15 B 7 C 27

CS CSM CAP/AACC Immunosuppressive Drugs 57 A 8 B 22

CT CT Activated Clotting Time 164 A 19 B 19

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


CT1 CT1 Activated Clotting Time 164 A 4 B 19

CT1Q CT1Q Quality Cross Check—ACT 46 A 1 B 6







CTKN CTKN Cytokines 212 A 1 B 16

CTQ CTQ Quality Cross Check—ACT 46 A 1 B 6

CY CY CAP/ACMG Cytogenetics, Online Images 246 A 29 B 1

CYBK CY CAP/ACMG Cytogenetics, Booklet 246 A 29 B 1

CYCGH CYCGH CAP/ACMG Constitutional Microarray 248 A 17 B 18

CYCMA CYCMA CAP/ACMG Oncology Microarray 248 A 8 B 2

CYF CYF CAP/ACMG FISH Constitutional/Hematologic Disorders

246 A 12 B 30

CYH CYH CAP/ACMG FISH, Paraffin-Embedded Tissue

247 A 19 B 6

CYHI CYHI CAP/ACMG HER2 Gene Amplification by FISH, Interpretation Only

285 A 19 B 6

CYI CYI CAP/ACMG FISH, Urothelial Carcinoma 246 A 22 B 2

CYJ CYP CAP/ACMG FISH, Paraffin-Embedded Tissue

247 A 22 B 2

CYK CYP CAP/ACMG FISH, Paraffin-Embedded Tissue

247 A 22 B 2

CYL CYP CAP/ACMG FISH, Paraffin-Embedded Tissue

247 A 22 B 2

CYS CYS Cystatin C 74 A 26 B 16

CZ C Chemistry/Therapeutic Drug Monitoring 54–56 A 8 B 1 C 27

CZ2X C Chemistry/TDM, Triple Volume 54–56 A 8 B 1 C 27

CZQ CZQ Quality Cross Check—Chemistry/Therapeutic Drug Monitoring

39 A 12 B 7

CZVM CZVM Chemistry/TDM, Validated Material 67 A 8 B 1 C 27

CZX C Chemistry/TDM, Double Volume 54–56 A 8 B 1 C 27

D D Bacteriology 173 A 1 B 7 C 4

D1 D1 Throat Culture 175 A 29 B 9 C 6

D2 D2 Urine Culture 175 A 29 B 9 C 6

D3 D3 N. gonorrhoeae Culture 175 A 29 B 9 C 6

D5 D5 Gram Stain 177 A 6 B 16 C 6

D6 D6 Rapid Group A Strep Antigen Detection 179 A 29 B 9 C 6

D8 D8 Group B Strep Detection 180 A 26 B 12 C 29

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 7

Prog Code

PFGCode


D9 D9 Rapid Group A Strep Antigen Detection, Waived

179 A 29 B 9

DADR1 DADR HLA Disease Association-Drug Risk 243 A 13 B 24

DADR2 DADR HLA Disease Association-Drug Risk 243 A 13 B 24

DAI DAI Urine Drug Adulterant/Integrity 99 A 8 B 9

DAT DAT Direct Antiglobulin Testing 228 A 22 B 11

DBGN ACM Dabigatran Anticoagulant Monitoring 163 A 12 B 25

DEX DEX Expanded Bacteriology 174 A 11 B 17 C 6

DFC DFC Drug-Facilitated Crime 109 A 1 B 30

DML DML Class I & II HLA Molecular Typing 240 A 16 B 1 C 28

DMPM DMPM Drug Monitoring for Pain Management 108 A 8 B 9

DPATH DPATH Digital Slide Program—Dermatopathology 273 A 14 B 13

DPATH1 DPATH Digital Slide Program—Dermpath, Additional Pathologist

273 A 14 B 13

DPIHC DPIHC Dermatopathology IHC 285 A 10 B 7

DSC CM Dipstick Confirmatory Testing 149 A 16 B 7

DY Y Ligand Assay—Testosterone, SHBG 84 A 26 B 20

E E Mycobacteriology 190 A 1 B 30

E1 E1 Mycobacteriology—Limited 190 A 22 B 23

EGFR EGFR EGFR 265 A 1 B 30

EHE1 EHE Expanded Virtual Peripheral Blood Smear 144 A 19 B 18

ELU ELU Eluate 228 A 15 B 28

EMB EMB Embryology 157 A 7 B 25

EPO Y Erythropoietin 88 A 26 B 20

ESR ESR Erythrocyte Sedimentation Rate 140 A 17 B 15

ESR1 ESR1 Erythrocyte Sedimentation Rate 140 A 17 B 15



ETB ETB Ethanol Biomarkers 103 A 1 B 30

ETME1 ETME Expanded Transfusion Medicine Exercises 233 A 8 B 27

EV EV Everolimus 58 A 20 B 14

EXM J Electronic Crossmatch 223 A 8 B 7 C 7

EXM2 JAT Electronic Crossmatch, Automated 225 A 16 B 21 C 27

F F Mycology and Aerobic Actinomycetes 191 A 25 B 3 C 23

F1 F1 Yeast 191 A 16 B 24 C 13

F3 F3 Candida Culture 192 A 1 B 6 C 8

FCAL FCAL Fecal Calprotectin 75 A 26 B 15

FCFS FCFS Fecal Fat 75 A 1 B 13

FCN FCN Antifilamentous Actin IgG Antibody 210 A 26 B 8

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


FF FF Fetal Fibronectin 88 A 28 B 29

FGAL FGAL Galactomannan 192 A 12 B 16

FH1 FH1 Hematology Automated Differential Series 136 A 25 B 3 C 20

FH1P FH1 Hematology Automated Differential Blood Cell ID

136 A 25 B 3 C 20



136 A 25 B 3 C 20



136 A 25 B 3 C 20

FH3Q FH3Q Quality Cross Check—Hematology 43 A 22 B 19



136 A 25 B 3 C 20




136 A 25 B 3 C 20




136 A 25 B 3 C 20




136 A 25 B 3 C 20



136 A 25 B 3 C 20



136 A 25 B 3 C 20

FL FL Flow Cytometry Combo (FL1/FL2) 215 A 8 B 14 C 11

FL1 FL Flow Cytometry, Lymphocyte Phenotype 215 A 8 B 14 C 11

FL2 FL Flow Cytometry, DNA Analysis 215 A 8 B 14 C 11

FL3 FL3 Flow Immunophenotypic Characterization of Leukemia/Lymphoma

215 A 2 B 14

FL4 FL4 Flow Cytometry, CD34+ 215 A 12 B 18

FL5 FL5 Flow Cytometry, Interpretation Only 216 A 8 B 16

FL6 FL6 Flow Cytometry—Post-Immunotherapy Analysis

216 A 24 B 29

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 9

Prog Code

PFGCode


FL7 FL7 Flow Cytometry—T-Cell Subsets Analysis 216 A 14 B 13

FL8 FL8 Flow Cytometry—Mature B-Cell Leukemia/Lymphoma Minimal Residual Disease

217 A 8 B 2

FL9 FL9 Flow Cytometry—Plasma Cell Myeloma Minimal Residual Disease

217 A 24 B 22

FLAC FLAC Fecal Lactoferrin 184 A 19 B 23

FLD FLD Body Fluid Chemistry 72 A 8 B 2

FLD2 FLD2 Body Fluid Chemistry 2 73 A 8 B 2

FLDQ FLDQ Quality Cross Check—Body Fluid Chemistry

40 A 5 B 4

FNA FNA Digital Slide Program in Fine-Needle Aspiration

298 A 19 B 18

FNA1 FNA Digital Slide Program in Fine-Needle Aspiration, Individual

298 A 19 B 18

FNAG FNAG Fine-Needle Aspiration Glass Slides, Laboratory

299 A 10 B 13

FNAG1 FNAG Fine-Needle Aspiration Glass Slides, Individual

299 A 10 B 13

FNPX ACM Fondaparinux Anticoagulant Monitoring 163 A 12 B 25

FOL K RBC Folate 88 A 6 B 19 C 8

FP FP Second Trimester Maternal Screening 87 A 15 B 2 C 8

FP1B FP First Trimester Maternal Screening, Free Beta

87 A 15 B 2 C 8

FP1T FP First Trimester Maternal Screening, Total Beta

87 A 15 B 2 C 8

FPX FP Second Trimester Maternal Screening, Additional Material

87 A 15 B 2 C 8

FR FR Forensic Pathology 302 A 17 B 22

FR1 FR Forensic Pathology, Additional Pathologist 302 A 17 B 22

FSER FSER Fungal Serology 193 A 19 B 23

FSM FSM Fungal Smear 193 A 22 B 4

FT FT Fructosamine 75 A 3 B 8

FTC FTC Forensic Toxicology, Criminalistics 105 A 8 B 12 C 15

G G Syphilis Serology 214 A 12 B 26 C 13

G6PDS G6PDS Glucose-6-Phosphate Dehydrogenase 75 A 22 B 11

GH2 GH2 Hemoglobin A1c, 3 Challenge 63 A 20 B 7

GH5 GH5 Hemoglobin A1c, 5 Challenge 63 A 20 B 20 C 7

GH5I GH5I Hemoglobin A1c, International 63 A 8 B 14 C 27

GHER2 GHER2 Gastric HER2 286 A 6 B 16

GHQ GHQ Quality Cross Check—Hemoglobin A1c 40 A 7 B 8

GIP GIP Gastrointestinal Panel, 2 Challenge 205 A 29 B 2

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


GIP5 GIP Gastrointestinal Panel, 5 Challenge 205 A 29 B 2 C 13

GLI GLI Glioma 266 A 15 B 16

GOCB CM Gastric Occult Blood 150 A 16 B 7

GSA GSA Glycated Serum Albumin 64 A 3 B 8

H GIH Antimitochondrial M2 Antibody 210 A 26 B 27

HBF HBF Fetal Red Cell Detection 228 A 26 B 1

HBVL HVL Hepatitis B Viral Load, 3 Challenge 200 A 19 C 28

HBVL5 HVL Hepatitis B Viral Load, 5 Challenge 200 A 19 B 25 C 28

HC1 HC1 C. trachomatis Antigen Detection (DFA) 184 A 8 B 12 C 25

HC2 HC2 Herpes Simplex, Antigen Detection (DFA) 198 A 8 B 12 C 25

HC3 HC3 C. trachomatis Antigen Detection (EIA) 184 A 25 B 26 C 7

HC4 HC4 Herpes Simplex Virus, Culture 198 A 22 B 7 C 20

HC6 HC6 C. trachomatis/N. gonorrhoeae by Nucleic Acid Amplification (NAA)

188 A 1 B 17 C 20

HC6X HC6 C. trachomatis/N. gonorrhoeae by Nucleic Acid Amplification (NAA), Additional Material

188 A 1 B 17 C 20

HC7 HC7 C. trachomatis/N. gonorrhoeae with DNA 188 A 1 B 19 C 11

HCC HCC Waived Combination 66 A 8 B 20

HCC2 HCC2 Waived Combination 66 A 1 B 14 C 13 D 11

HCG S HCG, Serum 208 A 22 B 16 C 15

HCRT CAR High-Sensitivity Cardiac Markers CRT 60 A 16 B 18 C 5

HCRTI CAR High-Sensitivity Cardiac Markers CRTI 60 A 16 B 18 C 5

HCV2 HVL Hepatitis C Viral Load 200 A 19 B 25 C 28

HE HE Hematology—Basic 136 A 25 B 3 C 20

HEP HE Hematology—Basic with Blood Cell ID 136 A 25 B 3 C 20

HER2* HER2 HER2 Immunohistochemistry 286 A 15 B 2

HFC HFC Hemocytometer Fluid Count 150 A 2 B 6

HFCI HFCI Hemocytometer Fluid Count, International 151 A 13 B 6

HG HG Hemoglobinopathy 140 A 8 B 9

HGM HGM CAP/ACMG Hemoglobinopathies Genotyping

252 A 1 B 8

HIVG HIV HIV Genotyping 200 A 19 B 25 C 28

HMS CR Homocysteine 64 A 29 B 1

HPATH HPATH Hematopathology Online Education 145 A 17 B 15

HPATH1 HPATH Hematopathology Online Education, Additional Participant

145 A 17 B 15

HPS HPS H. pylori Antigen, Stool 184 A 12 B 13

HPV HPV Human Papillomavirus 198 A 21 B 18

HQBX1 HQBX1 CAP/NSH HistoQIP Gastrointestinal Biopsy 283 A 25 B 21

*Ship date subject to change.

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 11

Prog Code

PFGCode


HQBX2 HQBX2 CAP/NSH HistoQIP Dermatologic Biopsy 283 A 25 B 21

HQBX3 HQBX3 CAP/NSH HistoQIP Urogenital Tract Biopsy 283 A 25 B 21

HQBX4 HQBX4 CAP/NSH HistoQIP Gynecological Biopsy 283 A 25 B 21

HQIHC HQIHC CAP/NSH HistoQIP Immunohistochemistry 281 A 25 B 21

HQIP HQIP CAP/NSH HistoQIP 277 A 25 B 21

HQIPBX HQIPBX CAP/NSH HistoQIP Biopsy Series 282 A 25 B 21

HQISH HQISH CAP/NSH HistoQIP In Situ Hybridization (Kappa/Lambda)

278 A 25 B 21

HQMEL HQMEL CAP/NSH HistoQIP Melanoma IHC 279 A 25 B 21

HQMMR HQMMR CAP/NSH HistoQIP Mismatch Repair IHC 281 A 25 B 21

HQNEU HQNEU CAP/NSH HistoQIP Central Nervous System IHC

278 A 25 B 21

HQNSC HQNSC CAP/NSH HistoQIP Non-small Cell Lung Carcinoma IHC

282 A 25 B 21

HQWSI HQWSI HQIP Whole Slide Image Quality Improvement Program

280 A 25 B 21

HSCRP CR High-Sensitivity C-Reactive Protein 64 A 29 B 1

HTNT CAR High-Sensitivity Cardiac Markers TNT 60 A 16 B 18 C 5

HUEP HUEP Human Epididymis Protein 4 89 A 19 B 6

HV2 HIV HIV Viral Load 200 A 19 B 25 C 28

I I Instrumentation 132 A 29 B 26 C 29

ICSP ICSP CAP/ACMG Inherited Cancer Sequencing Panel

252 A 23 B 17

ID1 ID1 Nucleic Acid Amplification, Viruses 198 A 12 B 18

ID1T ID1 Nucleic Acid Amplification, JC & BK 198 A 12 B 18

ID2 ID2 Nucleic Acid Amplification, Respiratory 199 A 12 B 18

ID3 ID3 Influenza A, Influenza B, and RSV by NAA 199 A 8 B 12 C 29

ID5 ID5 HSV, VZV—Molecular 200 A 12 B 30 C 13

IDM5 IDM5 Meningitis/Encephalitis Panel, 5 Challenge 203 A 1 B 14 C 25

IDME IDME Meningitis/Encephalitis Panel 203 A 5 B 30

IDN IDO NAA, Organisms Without MTB 202 A 12 B 18

IDO IDO Nucleic Acid Amplification, Organisms 202 A 12 B 18

IDPN IDPN Infectious Disease, Pneumonia Panel 204 A 12 B 30 C 13

IDR IDR Infectious Disease, Respiratory Panel 203 A 8 B 12 C 29

IFS IFS Interfering Substances 133 A 4

IG S Immunology—General 208 A 22 B 16 C 15

IGHV IGHV IGHV Mutation Analysis 263 A 30 B 2

IGX S Immunology—General, Double Volume 208 A 22 B 16 C 15

IL S Immunology—Comprehensive 208 A 22 B 16 C 15

IM S Infectious Mononucleosis 208 A 22 B 16 C 15

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


IMD1 IMD CAP/ACMG Mitochondrial DNA Deletion Syndrome

254 A 29 B 27

IMD2 IMD CAP/ACMG MCAD 254 A 29 B 27

IMD3 IMD CAP/ACMG Mitochondrial Cytopathies 254 A 29 B 27

IMW IMW Infectious Mononucleosis, Waived 209 A 29 B 9

IND IND India Ink 193 A 10 B 6

ING Y Insulin, Gastrin, C-Peptide, and PTH 86 A 26 B 20

ISH ISH In Situ Hybridization 263 A 19 B 6

ISH2 ISH In Situ Hybridization, HER2 (ERBB2) 263 A 19 B 6

J J Transfusion Medicine—Comprehensive 222 A 8 B 7 C 7

J1 J1 Transfusion Medicine—Limited 222 A 8 B 7 C 7

JAT JAT Transfusion Medicine—Automated 223 A 16 B 21 C 27

JATE1 JAT Transfusion Medicine—Automated Education Challenge

223 A 16 B 21 C 27

JATQ JATQ Quality Cross Check—Transfusion Medicine

47 A 12 B 2

JE1 J Transfusion Medicine—Education Challenge

222 A 8 B 7 C 7

K K Ligand—General 82 A 6 B 19 C 8

KET KET Ketones 64 A 3 B 8

KI67 KI67 Ki-67 Immunohistochemistry Tissue Microarray

289 A 1 B 12

KIT KIT KIT/PDGFRA 265 A 12 B 25

KK K Ligand—General, Double Volume 82 A 6 B 19 C 8

KRAS KRAS KRAS 265 A 17 B 15

KSA KSA Kidney Stone Assessment 69 A 24 B 22

KVM KVM Ligand Assay—General, Validated Material 90 A 6 B 19 C 8

LBAS BAS Legionella Antigen Detection 180 A 1 B 8

LBC LBC Lamellar Body Count 151 A 19 B 25

LCW LCW Chemistry—Limited, Waived 64 A 1 B 11

LKM GIH Liver-Kidney Microsomal Antibody (Anti-LKM)

213 A 26 B 27

LN2 LN2 Chemistry, Lipid, Enzyme Calibration Verification/Linearity

120 A 12 B 11

LN2BV LN2BV Chem CVL Beck (Except AU), Vitros Calibration Verification/Linearity

120 A 12 B 11

LN3 LN3 Therapeutic Drug Monitoring Calibration Verification/Linearity

121 A 22 B 13

LN5 LN5 Ligand Assay Calibration Verification/Linearity

121-122 A 12 B 11

LN5S LN5S Ligand Assay, Siemens Calibration Verification/Linearity

121-122 A 12 B 11

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 13

Prog Code

PFGCode


LN6 LN6 Urine Chemistry Calibration Verification/Linearity

122 A 22 B 13

LN7 LN7 Immunology Calibration Verification/Linearity

123 A 19 B 11

LN8 LN8 Reproductive Endocrinology Calibration Verification/Linearity

123 A 6 B 27

LN9 LN9 Hematology Calibration Verification/Linearity

123 A 6 B 27

LN11 LN11 Serum Ethanol Calibration Verification/Linearity

124 A 11 B 6

LN12 LN12 C-Reactive Protein Calibration Verification/Linearity

124 A 19 B 26

LN12E LN12E C-Reactive Protein, Extended Calibration Verification/Linearity

124 A 19 B 26

LN13 LN13 Blood Gas Calibration Verification/Linearity 124-125 A 11 B 6

LN13C LN13 Blood Gas/Critical Care Calibration Verification/Linearity

124-125 A 11 B 6

LN15 LN15 Hemoglobin A1c Accuracy Calibration Verification/Linearity

125 A 9 B 14

LN16 LN16 Homocysteine Calibration Verification/Linearity

125 A 8 B 13

LN17 LN17 Whole Blood Glucose Calibration Verification/Linearity

125 A 22 B 23

LN18 LN18 Reticulocyte Calibration Verification/Linearity

126 A 22 B 27

LN19 LN19 Reticulocyte Calibration Verification/Linearity

126 A 15 B 13

LN20 LN20 Urine Albumin Calibration Verification/Linearity

126 A 12 B 11

LN21 LN21 High-Sensitivity CRP Calibration Verification/Linearity

126 A 12 B 11

LN22 LN22 Flow Cytometry Calibration Verification/Linearity

126 A 29 B 4

LN23 LN23 Prostate-Specific Antigen Calibration Verification/Linearity

127 A 24 B 22

LN24 LN24 Creatinine Accuracy Calibration Verification/Linearity

127 A 18 B 16

LN25 LN25 Troponin I Calibration Verification/Linearity 127 A 23 B 21

LN27 LN27 Troponin T Calibration Verification/Linearity

127 A 23 B 21

LN30 LN30 B-Type Natriuretic Peptides Calibration Verification/Linearity

128 A 15 B 14

LN31 LN31 Immunosuppressive Drugs Calibration Verification/Linearity

128 A 20 B 26

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


LN32 LN32 Ammonia Calibration Verification/Linearity 128 A 24 B 29

LN33 LN33 Serum Myoglobin Calibration Verification/Linearity

128 A 24 B 29

LN34 LN34 Tumor Markers Calibration Verification/Linearity

129 A 19 B 18

LN35 LN35 Thrombophilia Calibration Verification/Linearity

129 A 2 B 24

LN36 LN36 Heparin Calibration Verification/Linearity 129 A 30 B 28

LN37 LN37 von Willebrand Factor Antigen Calibration Verification/Linearity

129 A 27 B 26

LN38 LN38 CMV Viral Load Calibration Verification/Linearity

130 A 2 B 31

LN39 LN39 HIV Viral Load Calibration Verification/Linearity

130 A 3 B 1

LN40 LN40 Vitamin D Calibration Verification/Linearity 130 A 3 B 1

LN41 LN41 Procalcitonin Calibration Verification/Linearity

130 A 4 B 9

LN42 LN42 D-Dimer Calibration Verification/Linearity 131 A 12 B 11

LN44 LN44 Fibrinogen Calibration Verification/Linearity

131 A 11 B 9

LN45 LN45 HCV Viral Load Calibration Verification/Linearity

130 A 27 B 2

LN46 LN46 C-Peptide/Insulin Calibration Verification/Linearity

131 A 11 B 2

LPE ELP Lipoprotein Electrophoresis 76 A 26 B 9

LPX LPX Laboratory Preparedness Exercise 186 A 5 B 7

M M Cerebrospinal Fluid Chemistry 74 A 5 B 30

MBT MBT Micro Bench Tools Competency 174 A 29 B 27

MC3 MC3 Urine Colony Count 177 A 29 B 9 C 6

MC4 MC4 Urine Colony Count—Combination 177 A 29 B 9 C 6

ME ME Monitoring Engraftment 242 A 23 B 10

MGEN MGEN Mycoplasma genitalium, Molecular 188 A 24 B 29

MGL1 MGL1 Molecular Genetics Series 253–254 A 15 B 9





MHO MHO MHO, Lymphoma 267 A 20 B 19

MHO1 MHO MHO1, Lymphoma, Double Volume 267 A 20 B 19

MHO2 MHO MHO2, Leukemia Only 267 A 20 B 19

MHO3 MHO MHO3, Leukemia Only, Double Volume 267 A 20 B 19

MHO5 MHO DNA Extraction & Amplification FFPE 264, 267 A 20 B 19

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 15

Prog Code

PFGCode


MK MK Immunohistochemistry 284 A 16 B 16

MMA MMA MMA and Active B13 82 A 19 B 6

MMR MMR DNA Mismatch Repair 288 A 14 B 18

MPA CSM Mycophenolic Acid 58 A 8 B 22

MRD MRD Minimal Residual Disease, BCR/ABL1 p210 267 A 20 B 5

MRD1 MRD Minimal Residual Disease, BCR/ABL1 p190 267 A 20 B 5

MRD2 MRD Minimal Residual Disease, PML/RARA 267 A 20 B 5

MRS MRS Methicillin-resistant Staphylococcus aureus, 2 Challenge

185 A 1 B 4

MRS2M MRS2M MRSA Screen, Molecular, 2 Challenge 185 A 29 B 1

MRS5 MRS5 Methicillin-resistant Staphylococcus aureus, 5 Challenge

185 A 1 B 1 C 4

MRS5M MRS5M MRSA Screen, Molecular, 5 Challenge 185 A 29 B 12 C 1

MSI MSI Microsatellite Instability 263 A 14 B 18

MTBR MTBR Molecular MTB Detection and Resistance 190 A 7 B 15

MTP MTP Multigene Tumor Panel 266 A 16 B 23

MTR5 MTR5 Molecular MTB Detection and Resistance, 5 Challenge

190 A 7 B 15

MVM MVM Cerebrospinal Fluid, Validated Material 80 A 5 B 30

MVP MVP Molecular Vaginal Panel 188 A 22 B 6 C 15

MXB MX HLA Crossmatching, Antibody Screen, and Antibody Identification (Class I/Class II)

240 A 30 B 27 C 16

MXC MX HLA Crossmatching, Antibody Screen, and Antibody Identification (Class I/Class II)

240 A 30 B 27 C 16

MXE MX HLA Crossmatching, Antibody Screen, and Antibody Identification (Class I/Class II)

240 A 30 B 27 C 16

MYCB MYCB c-Myc/Bcl-2 Immunohistochemistry Tissue Microarray

289 A 12 B 11

MYG MYG Myoglobin, Urine 69 A 22 B 19

N N Urine Chemistry—Special 69 A 22 B 12

NAT NAT Nucleic Acid Testing 236 A 15 B 12 C 11

NB NB Neonatal Bilirubin, 5 Challenge 65 A 1 B 14 C 18

NB2 NB2 Neonatal Bilirubin, 2 Challenge 65 A 1 B 18

NEO NEO Neoplastic Cellularity 264 A 8 B 20

NGC NGC Non-GYN Interlaboratory Comparison, Lab 297 1/19/21 -

2/8/21

4/12/21 -

5/3/21

7/19/21 -

8/9/21

10/11/21 -

11/1/21

NGC1 NGC Non-GYN Interlaboratory Comparison, Indv 297 1/19/21 -

2/8/21

4/12/21 -

5/3/21

7/19/21 -

8/9/21

10/11/21 -

11/1/21

NGS NGS Next-Generation Sequencing—Germline 259 A 1 B 13

NGSB1 NGSB NGS Bioinformatics for Illumina 260 A 1 B 22

NGSB2 NGSB2 NGS Bioinformatics for Ion Torrent 260 A 1 B 22

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


NGSBV NGSBV NGS Bioinformatics Somatic, Validated Material

262 A 7 B 22

NGSE NGSE NGS Undiagnosed Disorders-Exome 261 A 1 B 13

NGSHM NGSHM NGS Hematologic Malignancies 260 A 26 B 25

NGSST NGSST NGS Solid Tumor 259 A 22 B 27

NIPT NIPT Noninvasive Prenatal Testing 88 A 26 B 13

NOB NOB Novel Opioids and Benzodiazepines 106 A 13 B 31

NP NP Neuropathology Program 291 A 15 B 13

NP1 NP Neuropathology Program, Additional Pathologist

291 A 15 B 13

NTA NTA Nicotine and Tobacco Alkaloids 103 A 27 B 2

NX N Urine Chemistry—Special, Double Volume 69 A 22 B 12

OCB CM Occult Blood 151 A 16 B 7

OCBQ OCBQ Quality Cross Check—Occult Blood 44 A 12 B 18

OFD OFD Oral Fluid for Drugs of Abuse 101 A 1 B 24 C 30 D 29

OLI M CSF Chemistry and Oligoclonal Bands 74 A 5 B 30

P P Parasitology 194 A 1 B 21 C 1

P16 P16 p16 Immunohistochemistry Tissue Microarray

289 A 12 B 15

P3 P Parasitology—Fecal Suspension, Immunoassay

194 A 1 B 21 C 1

P4 P Parasitology—Fecal Suspension, PVA, Immunoassay

194 A 1 B 21 C 1

P5 P Parasitology, Giardia/Crypto Immunoassay 194 A 1 B 21 C 1

PAP Prog PAP PAP PT and Education Programs 292-293 For PAP shipping information, refer to page 23

PARF PARF Parentage/Relationship Test—Filter Paper 237 A 16 B 21 C 20

PCARI PCARM Plasma Cardiac Markers International 65 A 1 B 7 C 11

PCARM PCARM Plasma Cardiac Markers 65 A 1 B 7 C 11

PCARMX PCARM Plasma Cardiac Markers, Double Volume 65 A 1 B 7 C 11

PCNEO PCNEO Flow Cytometry—Plasma Cell Neoplasms 218 A 27 B 12

PCP1 PCP1 Pneumocystis, Calcofluor White Stain 193 A 1 B 6

PCP2 PCP2 Pneumocystis, DFA Stain 193 A 1 B 6

PCP4 PCP4 Pneumocystis, GMS Stain 193 A 1 B 6

PCT PCT Procalcitonin 77 A 1 B 23

PDL1 PDL1 PD-L1 288 A 24 B 8

PEX PEX Expanded Parasitology 195 A 12 B 11

PF PF Platelet Aggregation 166 A 8 B 11

PF1 PF1 Platelet Function 166 A 8 B 11

PGX PGX Pharmacogenetics 256 A 19 B 13

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 17

Prog Code

PFGCode


PGX1 PGX IL28B Genotyping 256 A 19 B 13

PGX2 PGX HLA Drug Hypersensitivity 256 A 19 B 13

PGX3 PGX DPYD, TPMT, UGT1A1 Genotyping 256 A 19 B 13

PHG PHG Plasma Hemoglobin 76 A 29 B 13

PIA PIA Drug-Specific Platelet Aggregation 167 A 12 B 18

PIAX PIA Drug-Specific Platelet Aggregation, Double Volume

167 A 12 B 18

PIP PIP Performance Improvement Program in Surgical Pathology

271 A 15 B 7 C 13 D 6

PIP1 PIP Performance Improvement Program in Surgical Pathology, Additional Pathologist

271 A 15 B 7 C 13 D 6

PIPW PIPW Online Performance Improvement Program, Surgical Pathology

270 A 15 B 7 C 13 D 6

PIPW1 PIPW Online Performance Improvement Program, Surgical Pathology, Additional Pathologist

270 A 15 B 7 C 13 D 6

PLA PLA Lipoprotein-Associated Phospholipase A2 75 A 29 B 27

PLTM PLTM Platelet Mapping 169 A 8 B 11

PM1 PM1 CD117, IHC Tissue Microarray 284 A 7

PM2 PM2 ER/PgR, IHC Tissue Microarray 286 A 24 B 1

PM3 PM3 CD20, IHC Tissue Microarray 287 A 22 B 13

PM5 PM5 IHC Tissue Microarray Series 284 A 19

PM6 PM6 Anaplastic Lymphoma Kinase IHC TMA 287 A 22 B 7

PNA1 PNA PNA FISH for Staphylococcus 182 A 19 B 18

PNA2 PNA PNA FISH for Yeast 182 A 19 B 18

PNH* PNH Flow Cytometry—PNH Immunophenotyping 218 A 27 B 26

POC1 POC1 POC hCG Competency 50 May be purchased any time during the year

POC2 POC2 POC Glucose Competency 50 May be purchased any time during the year

POC3 POC3 POC Urine Dipstick Competency 50 May be purchased any time during the year

POC4 POC4 POC Strep Screen Competency 50 May be purchased any time during the year

POC6 POC6 POC PT/INR, CoaguChek XS+ Competency 50 May be purchased any time during the year

POC7 POC7 POC Waived Glucose & Hemoglobin Competency

50 May be purchased any time during the year

POC8 POC8 POC Influenza A/B Antigen Detection Competency


POC9 POC9 POC Fecal Occult Blood Competency 50 May be purchased any time during the year

POC10 POC10 POC Blood Gases Competency 51 May be purchased any time during the year

POC11 POC11 POC Blood Gases, i-STAT Competency 51 May be purchased any time during the year

POC12 POC12 POC Plasma Cardiac Markers Competency 51 May be purchased any time during the year

POC14 POC14 POC Medtronic ACT/ACT, i-STAT Competency


Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


POC15 POC15 POC Hemochron Jr IL GEM ACT-LR Competency


POC16 POC16 POC Hemochron Jr Signature IL GEM Competency


PS PS Platelet Serology 229 A 15 B 18

PTHQ PTHQ Quality Cross Check—Parathyroid Hormone

41 A 17 B 8

PV SEM Semen Analysis 156 A 19 B 25

PV1 SEM Postvasectomy Sperm Count—Automated 156 A 19 B 25

QF QF M. tuberculosis-Stimulated Infection Detection

213 A 17 B 18

QP211 QPR Antimicrobial Susceptibility Testing: Monitoring and Trend Analysis

25 A 7**

QP212 QPR Technical Competency Assessment of Gram Stains

26 B 15

QP213 QPR Physician Satisfaction with Clinical Laboratory Services

27 C 7

PRO QPR Three Quality Management Tools (QP211, QP212, QP213)

22 B 15 C 7 A 7**

QT1 QTR Patient Identification Accuracy 29 B 15 C 14 D 13 A 7**

QT2 QTR Blood Culture Contamination 29 B 15 C 14 D 13 A 7**

QT3 QTR Laboratory Specimen Acceptability 30 B 15 C 14 D 13 A 7**

QT4 QTR In-Date Blood Product Wastage 30 B 15 C 14 D 13 A 7**

QT5 QTR Gynecologic Cytology Outcomes 35 B 15 C 14 D 13 A 7**

QT7 QTR Satisfaction with Outpatient Specimen Collection

31 B 15 C 14 D 13 A 7**

QT8 QTR Stat Test Turnaround Time Outliers 31 B 15 C 14 D 13 A **

QT10 QTR Critical Values Reporting 32 B 15 C 14 D 13 A 7**

QT15 QTR Troponin Turnaround Times 33 B 15 C 14 D 13 A 7**

QT16 QTR Corrected Results 34 B 15 C 14 D 13 A 7**

QT17 QTR Outpatient Order Entry Errors 34 B 15 C 14 D 13 A 7**

QTC QTR Clinical Pathology Module (10 CP QT Monitors)

22 B 15 C 14 D 13 A 7**

QTP QTR CP/AP Quality Module (11 CP/AP QT Monitors)

22 B 15 C 14 D 13 A 7**

R R Trace Metals 78 A 30 B 26

RAG RAG Red Blood Cell Antigen Genotyping 226 A 8 B 18

RAP Y Renin and Aldosterone 89 A 26 B 20

RBCAT RBCAT Red Blood Cell Antigen Typing 226 A 22 B 1

RDS RDS Rheumatic Disease Special Serologies 213 A 6 B 16

RETT RETT CAP/ACMG Rett Syndrome (MECP2) 256 A 1 B 13

**This ship date is in December 2020.

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 19

Prog Code

PFGCode


RF S Rheumatoid Factor 208 A 22 B 16 C 15

RFAV1 RFAV Rare Flow Antigen Validation, CD1a 219 A 20 B 19

RFAV2 RFAV2 Rare Flow Antigen Validation, CD103 219 A 20 B 19

RFAV3 RFAV3 Rare Flow Antigen Validation, CD30 219 A 25 B 30

RFX S Rheumatoid Factor, Double Volume 208 A 22 B 16 C 15

RHCVW RHCVW Anti-HCV, Rapid Methods, Waived 235 A 26 B 1

RMAL RMAL Rapid Malaria 195 A 24 B 15

RMC RMC Routine Microbiology Combination 176 A 29 B 9 C 6

RNA RNA Fusion RNA 265 A 23 B 17

ROM1 ROM1 Placental Alpha Microglobulin 1 (PAMG-1) 152 A 10 B 13

RT RT Reticulocyte 141 A 25 B 13

RT2 RT2 Reticulocyte 141 A 25 B 13


RT3Q RT3Q Quality Cross Check—Reticulocyte 43 A 14 B 13


RT4Q RT4Q Quality Cross Check—Reticulocyte 43 A 14 B 13

RTQ RTQ Quality Cross Check—Reticulocyte 43 A 14 B 13

RUB S Rubella 208 A 22 B 16 C 15

RUBX S Rubella, Double Volume 208 A 22 B 16 C 15

RUR RUR Rapid Urease 186 A 26 B 9

RVBN ACM Rivaroxaban Anticoagulant Monitoring 163 A 12 B 25

RWBC RWBC Rapid Total Whole Blood Cell Count 140 A 12 B 16 C 6

S2 S2 Immunology—Special 209 A 6 B 9 C 13

S4 S2 Immunology—Special, Limited 209 A 6 B 9 C 13

S5 S2 Immunology—Special, H. pylori IgG Antibody

209 A 6 B 9

SALC SALC Salivary Cortisol 77 A 13 B 31

SARC SARC Sarcoma Translocation 264 A 11 B 23

SBAS BAS S. pneumoniae Antigen Detection 180 A 1 B 8

SC SEM Sperm Count 156 A 19 B 25

SC1 SEM Automated Sperm Count 156 A 19 B 25

SCDD SCDD Synthetic Cannabinoid/Designer Drugs 106 A 29 B 20

SCM1 SCM Urine Hemosiderin, Prussian Blue 152 A 15 B 8

SCM2 SCM Urine Eosinophils, Wright Stain 152 A 15 B 8

SCO SCO Serum Carryover 134 A 10

SCP SCP Stem Cell Processing 231 A 6 B 12

SCS SCS Sickle Cell Screening 142 A 1 B 9

SDS SDS Serum Drug Screening 102 A 22 B 1

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


SE SE Diagnostic Allergy 213 A 29 B 9 C 22

SEC SEC CAP/ACMG DNA Sequencing Interpretation 255 A 19 B 6

SEC1 SEC1 CAP/ACMG DNA Sequencing 255 A 26 B 25

SFLC SFLC Serum Free Light Chains 214 A 12 B 11

SM SEM Sperm Morphology 156 A 19 B 25

SM1CD SPCD Sperm Morphology, Online 156 A 19 B 25

SM2CD SPCD Sperm Viability, Online 156 A 19 B 25

SMCD SPCD Sperm Count and Motility, Online 156 A 19 B 25

SO SO Blood Oximetry 94 A 22 B 12 C 25

SOQ SOQ Quality Cross Check—Blood Oximetry 42 A 19 B 30

SP SP Stool Pathogens 186 A 17 B 1

SP1 SP Norovirus 186 A 17 B 1

SPE ELP Protein Electrophoresis 76 A 26 B 9

SPN SP Stool Pathogen, without Shiga Toxin 186 A 17 B 1

ST ST Shiga Toxin 187 A 16 B 2

STFR STFR Soluble Transferrin Receptor 80 A 19 B 23

SV SEM Sperm Viability 156 A 19 B 25

SW1 SW Sweat Analysis 79 A 11 B 12



T T Toxicology 96 A 1 B 19 C 11

TBLA TBLA Total Bile Acids 78 A 20 B 16

THCB THCB Blood Cannabinoids 107 A 12 B 30

TICP TICP Touch Imprint/Crush Preparation 296 A 21 B 13

TICP1 TICP Touch Imprint/Crush Prep, Additional Participant

296 A 21 B 13

TM TM Tumor Markers 89 A 4 B 19

TMCA TMCA Transfusion Medicine Comprehensive—Competency Assessment

229 A 8 B 7 C 7

TMCAD TMCAD Direct Antiglobulin Test—Competency Assessment

229 A 22 B 11

TMCAE TMCAE Eluate Competency Assessment 229 A 15 B 28

TMCAF TMCAF Fetal Red Cell Quantitation—Competency Assessment

230 A 26 B 1

TMO TMO Ticks, Mites, and Other Arthropods 195 A 8 B 26

TMU TMU Trace Metals, Urine 104 A 8 B 9

TMWB TMWB Trace Metals, Whole Blood 104 A 22 B 27

TMX TM Tumor Markers, Double Volume 89 A 4 B 19

TNT5 CAR Troponin T, 5 Challenge 60 A 16 B 18 C 5

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 21

Prog Code

PFGCode


TPM TPM CAP/ACMG Thrombophilia Mutations 257 A 15 B 20

TRC TRC Transfusion-Related Cell Count 228 A 4 B 10 C 23

TTD TTD Tick Transmitted Diseases 206 A 8 B 13

TVAG TVAG T. vaginalis, Molecular 189 A 17 B 15

U U Urine Chemistry—General 68 A 1 B 12

UAA UAA Automated Urine Microscopy 149 A 15 B 26

UAA1 UAA1 Automated Urine Microscopy 149 A 15 B 26

UBJP ELP Urine Bence Jones Protein 76 A 26 B 9

UDC UDC CAP/AACC Forensic Urine Drug Test, Confirmatory

100 A 4 B 26 C 26 D 1

UDS UDS CAP/AACC Urine Drug Testing, Screening 98 A 8 B 14 C 4

UDS6 UDS6 CAP/AACC Urine Drug Testing, Screening, Limited

98 A 8 B 4

UDSM UDSM Urine Drug Testing, Screen, Validated Material

110 A 8 B 14 C 4

UHCG UHCG Urine hCG 152 A 22 B 16 C 13

UMC UMC Urine Albumin and Creatinine, Semiquant 153 A 17 B 20

UPBG UPBG Porphobilinogen, Urine 70 A 26 B 1

URC CRS Urine Crystals 149 A 28 B 29

UT UT Urine Toxicology 96 A 1 B 19 C 11

UTCO UTCO Urine Toxicology Carryover 134 A 10

UVM UVM Urine Chemistry—General, Validated Material

70 A 1 B 12

V V Viscosity 214 A 6 B 4

VBDM VBDM Vector-Borne Disease—Molecular 201 A 24 B 6

VBF VBF Virtual Body Fluid 148 A 29 B 30

VBP VBP Virtual Biopsy Program 272 A 22 B 24 C 23 D 1

VBP1 VBP Virtual Biopsy Program, Additional Pathologist

272 A 22 B 24 C 23 D 1

VES VES Viscoelastic Studies 166 A 12 B 23

VF VF Vitreous Fluid, Postmortem 102 A 8 B 9

VGS1 VGS1 Virtual Gram Stain Basic Competency 179 A 19 B 18

VGS2 VGS2 Virtual Gram Stain Advanced Competency 179 A 19 B 18

VIP VIP Variant Interpretation Only 258 A 26

VIP1 VIP Variant Interpretation Only, Additional Participant

258 A 26

VITD VITD 25-OH Vitamin D, Total 84 A 26 B 22

VLS VLS BK, CMV, and EBV Viral Load 200 A 25 B 21

VLS2 VLS Viral Load 200 A 25 B 21 C 29

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


VM1 VM Viral Markers—Series 1 234 A 19 B 10 C 23


VM3 VM Viral Markers—Series 3 234 A 19 B 10

VM4 VM Viral Markers—Series 4 235 A 19 B 10



VM6X VM Viral Markers—Series 6, Additional Material

235 A 19 B 10 C 23

VPBS VPBS Virtual Peripheral Blood Smear 143 A 4 B 26

VR1 VR1 Virology Culture 197 A 25 B 17 C 20

VR2 VR2 Virology Antigen Detection (DFA) 197 A 15 B 12 C 1

VR3 VR3 Infectious Disease Serology 206 A 15 B 1

VR3M VR3 Infectious Disease Serology, Mumps 206 A 15 B 1

VR4 VR4 Virology Antigen Detection (Non-DFA) 197 A 1 B 3 C 8

VRE VRE Vancomycin-resistant Enterococcus 189 A 19 B 23

VS VS Vaginitis Screen Antigen Detection 187 A 29 B 26 C 25

VS1 VS Vaginitis Screen, T. vaginalis 187 A 29 B 26 C 25

VS2 VS2 Vaginitis Screen, Virtual Gram Stain 189 A 8 B 6

WBCR WBCR Whole Blood Creatinine 67 A 22 B 26 C 22

WBGQ WBGQ Quality Cross Check—Whole Blood Glucose 39 A 29 B 7

WID WID Worm Identification 195 A 29 B 1

WP3 WP3 Whole Blood PT/INR, i-STAT 168 A 8 B 3 C 20

WP4 WP4 Whole Blood Citrated PT Hemochron/IL GEM

168 A 8 B 3 C 20

WP6 WP6 Whole Blood Non-Citrated PT Hemochron/IL GEM

168 A 8 B 3 C 20

WP9 WP9 Whole Blood Coagulation—CoaguChek, XS Plus

168 A 25 B 17 C 30

WP10 WP10 Whole Blood Coagulation—CoaguChek XS System

168 A 17 B 30

Y Y Ligand—Special 84 A 26 B 20

YBC YBC Yeast Blood Culture, Molecular 192 A 26 B 23 C 6

YVM YVM Ligand—Special, Validated Material 90 A 26 B 20

YY Y Ligand—Special, Additional Volume 84 A 26 B 20

Z C TDM—General, Comprehensive 55–56 A 8 B 1 C 27

ZAP70 ZAP70 ZAP-70/CD49d Analysis by Flow Cytometry 219 A 1 B 16

ZE ZE Therapeutic Drug Monitoring—Extended 58 A 8 B 9

ZT ZT Therapeutic Drug Monitoring—Special 58 A 8 B 22

Surveys P

rogram S

hipping2021 Surveys Program Shipping

800-323-4040 | 847-832-7000 Option 1 | cap.org 23

2021 PAP Shipping

PAP Proficiency Testing With Education

DescriptionProgram Code (Institution)

Program Code (Individual) Page Calendar of Shipment Dates

PAP PT

PAPCPT (Conventional) APAPCPT 292

Laboratory will choose one of 20 dates for testing event

Feb 8 Mar 8 April

5 May 3 June 7

July 12 Aug 9 Sept

7Oct

4Nov

1

Feb 22

Mar 22

April 19

May 17

June 21

July 26

Aug 23

Sept 20

Oct 18

Nov 15

PAPKPT (SurePath) APAPKPT 292

PAPJPT (Combination) APAPJPT 292

PAPLPT (Liquid Based) APAPLPT 292

PAPMPT (ThinPrep) APAPMPT 292

Education No additional charge

Laboratory must choose from Series 1 or 2

Series 1, A mailing: February 8-March 1 Series 1, B mailing: August 9-August 30

Series 2, A mailing: May 10-June 1 Series 2, B mailing: November 1-November 22

Enrollment for laboratories with CLIA license with enrollees testing at affiliated sites

PPTENR 292 No shipments associated with this program

For additional programs for PAP PT, such as extra tests, retests, CAP provided proctors, and locum tenens, please call a Customer Contact Representative at 800-323-4040 or 847-832-7000 option 1.

PAP Education

DescriptionProgram Code (Institution)

Program Code (Individual) Page Calendar of Shipment Dates

PAP Education (Series 1 or 2)

PAPCE1 or 2 (Conventional) APAPCE1 or 2 293 Laboratory must choose from Series 1 or 2

PAPKE1 or 2 (SurePath) APAPKE1 or 2 293

Series 1, A mailing: February 8-March 1 Series 1, B mailing: August 9-August 30PAPJE1 or 2

(Combination) APAPJE1 or 2 293

PAPLE1 or 2 (Liquid Based) APAPLE1 or 2 293

Series 2, A mailing: May 10-June 1 Series 2, B mailing: November 1-November 22PAPME1 or 2

(ThinPrep) APAPME1 or 2 293

For international laboratories and other laboratories not subject to US regulations, that perform gynecologic cytopathology, participation in the CAP Cytopathology Glass Slide Education Program will fulfill the checklist requirement for participation in an interlaboratory peer-comparison educational program in gynecologic cytopathology.

Sur

veys

Pro

gram

Shi

ppin

g

Quality Management Tools Overview



2021 QP StudiesModules/Packages Program Codes

Individual QP Studies QP211, QP212, QP213

All Three QP Studies PRO

2021 QT MonitorsModules/Packages Program Codes

Individual Clinical Pathology (CP) MonitorsQT1, QT2, QT3, QT4, QT7, QT8,

QT10, QT15, QT16, QT17

Individual Anatomic Pathology (AP) Monitor QT5

Clinical Pathology Module – Includes all 10 CP QT Monitors QTC

Combined CP/AP Module – Includes all 11 QT Monitors QTP

Refer to the Quality Management Tools section of the Surveys catalog for program information.

Competency Assessment and Safety & Compliance Program

Your laboratory’s license for Competency Assessment Program is based on the number of individuals who will be using Competency Assessment Program—that is, the number of people for whom you will be assessing competency, not the number of employees in your laboratory. The Safety & Compliance course package is an addition to your Competency Assessment Program order. The same employees enrolled in Competency Assessment Program will have access to Safety & Compliance courses if the additional fee is paid. Refer to pages 15–17 of the Surveys catalog for program information.

Number of Users

Competency Assessment Program Safety & Compliance Courses*

Program Code Program Code

Up to 50 CA0050 XCA0050

51 to 250 CA0250 XCA0250

251 to 500 CA0500 XCA0500

*Safety & Compliance course package must be purchased in conjunction with Competency Assessment Program subscription. Not available for purchase separately.

Surveys Program Shipping · BCP2 KP Blood Cell ID, Limited 139 A 25 B 3 C 20 BCR CRS Bile Crystals...

Documents

Transcript of Surveys Program Shipping · BCP2 KP Blood Cell ID, Limited 139 A 25 B 3 C 20 BCR CRS Bile Crystals...